<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: The association between <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> and <z:hpo ids='HP_0002960'>autoimmune diseases</z:hpo> (AID) has been well described in the medical literature </plain></SENT>
<SENT sid="1" pm="."><plain>Several infectious agents have been implicated as inducers of <z:mp ids='MP_0001844'>autoimmune responses</z:mp>, such as Parvovirus B19, Epstein-Barr virus, cytomegalovirus, and <z:hpo ids='HP_0012115'>hepatitis</z:hpo> viruses </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: We examined 1,173 sera from patients with 14 different AID and 238 sera from geographically matched healthy controls, for evidence of prior <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with <z:e sem="disease" ids="C0035920" disease_type="Disease or Syndrome" abbrv="">rubella</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> samples were tested for the presence of serum antibodies against <z:e sem="disease" ids="C0035920" disease_type="Disease or Syndrome" abbrv="">rubella</z:e> using the Bio-Rad BioPlex 2200 system </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: As a group, patients with AID had a higher prevalence of IgM anti-<z:e sem="disease" ids="C0035920" disease_type="Disease or Syndrome" abbrv="">rubella</z:e> antibodies as compared to healthy controls (11.7% versus 5.4%; P = 0.001) </plain></SENT>
<SENT sid="5" pm="."><plain>The prevalence of IgM anti-<z:e sem="disease" ids="C0035920" disease_type="Disease or Syndrome" abbrv="">rubella</z:e> antibodies was significantly higher in 5/14 AID, namely in patients with giant cell <z:hpo ids='HP_0012089'>arteritis</z:hpo> (33.3%), primary <z:hpo ids='HP_0002613'>biliary cirrhosis</z:hpo> (24%), <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (20.6%), <z:e sem="disease" ids="C0085655" disease_type="Disease or Syndrome" abbrv="">polymyositis</z:e> (16%), and <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (16%) </plain></SENT>
<SENT sid="6" pm="."><plain>A similar prevalence of IgM anti-<z:e sem="disease" ids="C0035920" disease_type="Disease or Syndrome" abbrv="">rubella</z:e> antibodies was detected among controls from different countries </plain></SENT>
<SENT sid="7" pm="."><plain>A high prevalence of IgG anti-<z:e sem="disease" ids="C0035920" disease_type="Disease or Syndrome" abbrv="">rubella</z:e> antibodies was detected among patients with AID (89.9%) and controls </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: The increased prevalence of IgM anti-<z:e sem="disease" ids="C0035920" disease_type="Disease or Syndrome" abbrv="">rubella</z:e> antibodies in AID suggests a possible role for <z:e sem="disease" ids="C0035920" disease_type="Disease or Syndrome" abbrv="">rubella</z:e> in the etiopathogenesis of several AID </plain></SENT>
</text></document>